Biden Administration Commits $1.7B to SARS-CoV-2 Variant Sequencing, Surveillance

  • May 10, 2021

According to the White House, $1 billion will go toward helping the US Centers of Disease Control and Prevention and jurisdictional health departments conduct, expand, and improve activities around SARS-CoV-2 genome sequencing and mutation identification such as specimen collection and data sharing. An initial tranche of $240 million will be provided to states beginning in early May, with...

Read


COVID Test EUAs Updated with Pooled Serial Testing Option

  • May 10, 2021

The US Food and Drug Administration (FDA) has taken steps to make it easier to pool test samples for many molecular diagnostic tests for SAR-CoV-2, the virus that causes COVID-19.   The agency’s amendment to many test emergency use authorizations (EUAs) now allows sample pooling to screen asymptomatic individuals when the testing is performed at least once weekly as part of a screening...

Read


Summary of Private Payor Rate-Based Medicare Clinical Laboratory Fee Schedule-Updated

  • May 10, 2021

A laboratory, including an independent laboratory, a physician office laboratory, or hospital outreach laboratory that meets the definition of an applicable laboratory under the Clinical Laboratory Fee Schedule (CLFS), must report information, including laboratory test HCPCS codes, associated private payor rates, and volume data. CMS recently updated resources: Summary (PDF): Overview of...

Read


Billing for Hospice COVID-19 Testing

  • May 10, 2021

NGS - COVID-19 Testing as it Relates to the Terminal Illness NGS position is that the COVID-19 testing is related to the terminal illness and the GW modifier is not appropriate. Hospices should, therefore, provide payment to the lab. The rationale is that the hospice is responsible for the management and palliation of the terminal illness and related conditions. The test results provide the...

Read


COVID-19 Immunity from Liability Provisions, Adopted in Emergency, Now Repealed in New York State

  • May 10, 2021

On April 6, Governor Cuomo signed into law Chapter 96 of the Laws of 2021, which completely repeals the health care facility and provider COVID-19 immunity from liability provisions adopted in April 2020 as part of the Emergency or Disaster Treatment Protection Act (Public Health Law §§ 3080-82). As a result, health care facilities, their leadership, and health care professionals in general no...

Read


UHC - Training for the Genetic and Molecular Lab Testing Program Process

  • May 10, 2021

Starting June 1, 2021, we will begin managing prior authorizations for genetic and molecular tests. This change will impact the process for requesting prior authorization and registering lab tests. Here is where ordering providers and laboratories can find more information:  Training and information for requesting prior authorization Starting June 1, 2021,...

Read


UHC - COVID-19 Testing, Treatment, Coding & Reimbursement - Update

  • May 10, 2021

Last update: April 19, 2021 Testing, coding and reimbursement protocols and guidelines are established based on guidance from the Centers for Medicare & Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), state and federal governments and other health agencies. We’re closely monitoring COVID-19-related updates from these partners and updating this site as quickly...

Read


Regence - Medicare Advantage: Laboratory

  • May 10, 2021

Laboratory: effective May 1, 2021 COVID-19 Testing (Medicare #74) Added clarification to the policy regarding physician order requirements for antibody testing; the Centers for Medicare & Medicaid Services (CMS) considers antibody testing subject to the same physician order requirements applied to diagnostic COVID-19 viral testing

Read